Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shin

Showing results (931-940 of 957) with videos related to

Pageof 96
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2025
Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163Nabil F Saba, Yael Flamand, Derrick T Lin, et al.
Physical Review Letters|November 5, 2004
New limit on the T-violating transverse muon polarization in K+-->pi0mu+nu decaysM Abe, M Aliev, V Anisimovsky, et al.
Cell Systems|August 8, 2024
PanIN and CAF transitions in pancreatic carcinogenesis revealed with spatial data integrationAlexander T F Bell, Jacob T Mitchell, Ashley L Kiemen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancerJ Nemunaitis, S G Swisher, T Timmons, et al.
Cancer Immunology Research|August 15, 2025
Neoadjuvant immunotherapy promotes the formation of mature tertiary lymphoid structures in a remodeled pancreatic tumor microenvironmentDimitrios N Sidiropoulos, Sarah M Shin, Meredith Wetzel, et al.
Nature Medicine|November 25, 2025
A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trialMarina Baretti, Allison M Kirk, Brian H Ladle, et al.
Cancer Gene Therapy|May 16, 2000
Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53)N Yen, C G Ioannides, K Xu, et al.
The New England Journal of Medicine|October 26, 2007
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancerMarshall R Posner, Diane M Hershock, Cesar R Blajman, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Spatial multi-omics reveal intratumoral humoral immunity niches associated with tertiary lymphoid structures in pancreatic cancer immunotherapy pathologic respondersDimitrios N Sidiropoulos, Sarah M Shin, Meredith Wetzel, et al.
JAMA Oncology|May 23, 2024
Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled TrialNabil F Saba, Stuart J Wong, Tahseen Nasti, et al.
Pageof 96

Showing results (931-940 of 957) with videos related to

Sort By:
Pageof 96
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2025
Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163Nabil F Saba, Yael Flamand, Derrick T Lin, et al.
Physical Review Letters|November 5, 2004
New limit on the T-violating transverse muon polarization in K+-->pi0mu+nu decaysM Abe, M Aliev, V Anisimovsky, et al.
Cell Systems|August 8, 2024
PanIN and CAF transitions in pancreatic carcinogenesis revealed with spatial data integrationAlexander T F Bell, Jacob T Mitchell, Ashley L Kiemen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancerJ Nemunaitis, S G Swisher, T Timmons, et al.
Cancer Immunology Research|August 15, 2025
Neoadjuvant immunotherapy promotes the formation of mature tertiary lymphoid structures in a remodeled pancreatic tumor microenvironmentDimitrios N Sidiropoulos, Sarah M Shin, Meredith Wetzel, et al.
Nature Medicine|November 25, 2025
A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trialMarina Baretti, Allison M Kirk, Brian H Ladle, et al.
Cancer Gene Therapy|May 16, 2000
Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53)N Yen, C G Ioannides, K Xu, et al.
The New England Journal of Medicine|October 26, 2007
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancerMarshall R Posner, Diane M Hershock, Cesar R Blajman, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Spatial multi-omics reveal intratumoral humoral immunity niches associated with tertiary lymphoid structures in pancreatic cancer immunotherapy pathologic respondersDimitrios N Sidiropoulos, Sarah M Shin, Meredith Wetzel, et al.
JAMA Oncology|May 23, 2024
Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled TrialNabil F Saba, Stuart J Wong, Tahseen Nasti, et al.
Pageof 96